Royalty Pharma
RPRX
#646
Rank
โ‚ฌ34.71 B
Marketcap
60,07ย โ‚ฌ
Share price
1.90%
Change (1 day)
84.62%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): 1,61ย โ‚ฌ

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is 1,68ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 1,61ย โ‚ฌ a decrease over its 2024 EPS that were of 1,72ย โ‚ฌ.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)1,61ย โ‚ฌ-0.12%
20251,61ย โ‚ฌ-6.59%
20241,72ย โ‚ฌ
20201,36ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
2,79ย โ‚ฌ 66.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
26,72ย โ‚ฌ 1,493.07%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
4,32ย โ‚ฌ 157.48%๐Ÿ‡บ๐Ÿ‡ธ USA